Key Takeaway: The article discusses the evaluation of zero-shot scoring methods for predicting in vitro antibody binding. It emphasizes the importance of experimental validation in this context. The submission history and access options for the paper are also mentioned, highlighting the collaborative nature of arXivLabs.
Price reaction · baseline $2.295 (2023-12-12T15:22:00.000Z) · hit during market hours · clean, no other ABSI news in the window
day 0 close · peak
+2.4%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~12 mo
Medium dilution risk
Lead asset
ABS-201 Single Dose
Phase 1 · Androgenetic Alopecia (AGA)
Full Press Release Details
Submission history
Access Paper:
• View PDF
• HTML (experimental)
• TeX Source
Current browse context:
References & Citations
• NASA ADS
• Google Scholar
• Semantic Scholar
BibTeX formatted citation
Bookmark
• Author
• Venue
• Institution
• Topic
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs .